SCIENTIFIC SESSIONS Each scientific session presents a group of abstracts covering a similar topic. You'll hear a total of five abstracts presented during each session with interactive audience Q&A after the second and fifth abstracts are presented.
Saturday, April 17, 2021 S1 Epilepsy and Clinical
CME
1
Neurophysiology (EEG) 1
2:00 p.m. ET
S1.001
2:08 p.m. ET
S1.002
SCIENTIFIC SESSIONS
Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the MONEAD Study—Kimford J. Meador, Morris Cohen, David W. Loring, Carrie Brown, Chelsea Robalino, Page B. Pennell Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study—Michael R. Sperling, Bassel W. Abou-Khalil, Sami M. Aboumatar, Perminder JS Bhatia, Victor Biton, Pavel Klein, Gregory L. Krauss, David G. Vossler, Robert T. Wechsler, Louis Ferrari, Marc Kamin, Mindy Grall, William E. Rosenfeld
S2 Advances in MS Imaging 2:00 p.m. ET
S2.001
2:08 p.m. ET
S2.002
CME
1
Neurite Density Explains Cortical T1-/T2Weighted Ratio in Multiple Sclerosis—Paolo Preziosa, Piet Bouman, Svenja Kiljan, Martijn D Steenwijk, Alessandro Meani, Petra Pouwels, Maria Assunta Rocca, Massimo Filippi, Jeroen JG Geurts, Laura Jonkman
Questions and Answers
The Importance of Neuroradiology Input at a Neuroinflammatory Multidisciplinary Team (MDT) Meeting: Influencing and Optimising the Management of Patients with Multiple Sclerosis—Stephen Ramsay, Robert Spence, Rebecca Robinson, Niamh Turley, Debarata Bhattacharya, Adam Nelson, Peter Flynn, Aidan G. Droogan, Stella Elaine Hughes, Fiona Kennedy, Gavin V. McDonnell
2:24 p.m. ET
2:16 p.m. ET
2:16 p.m. ET
S1.003
Cenobamate Trough Plasma Concentrations in Patients With Uncontrolled Focal Seizures Achieving 50% and 100% Seizure Reduction in Two Randomized Clinical Studies—Stephen Greene, Marc Kamin
2:32 p.m. ET
S1.004
2:40 p.m. ET
S1.005
HMGB1 as a Therapeutic Target of Focal Cortical Dysplasia—Yang Zheng, Yi Wang, MeiPing Ding, Zhong Chen Efficacy, Safety, and Tolerability of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Pediatric Patients with Dravet Syndrome and Lennox-Gastaut Syndrome (ELEKTRA) —Cecil D. Hahn, Yuwu Jiang, Vicente Villanueva, Marta Zolnowska, Dimitrios Arkilo, Peter B. Forgacs, Mahnaz Asgharnejad, Ying Yan, Dennis J. Dlugos
2:48 p.m. ET
Questions and Answers
Questions and Answers
2:24 p.m. ET
S2.003
2:32 p.m. ET
S2.004
2:40 p.m. ET
S2.005
Relevance of NODDI to Characterise in Vivo the Microstructural Abnormalities of Multiple Sclerosis Cortex and Cortical Lesions: A 3T Study—Paolo Preziosa, Elisabetta Pagani, Raffaello Bonacchi, Laura Cacciaguerra, Massimo Filippi, Maria Assunta Rocca Vascular Disease Risk Factors in Multiple Sclerosis (MS) is Associated with Brain Adenosine Triphosphate Abnormalities: Dysmetabolism May Drive MS Disease Progression—Vijayshree Yadav, Michael Lane, Allison Fryman, Manoj K. Sammi Choroid Plexus Enlargement Characterizes Inflammatory Multiple Sclerosis—Vito Antonio Gerardo Ricigliano, Emanuele Morena, Annalisa Colombi, Matteo Tonietto, Mariem Hamzaoui, Emilie Poirion, Michel Bottlaender, Celine Louapre, Benedetta Bodini, Bruno Stankoff
2:48 p.m. ET
Questions and Answers
32 2021 AAN Annual Meeting
